-
New Practice Guideline Addresses Pharmacy Access to Buprenorphine
New PhARM-OUD Guideline for buprenorphine access in community pharmacies.Full story -
The ASAM Weekly for October 1st, 2024
Disparities in Medication Use for Criminal Justice System–Referred Opioid Use Disorder TreatmentFull story -
ASAM Applauds Bipartisan Congressional Letter Urging DEA to Finalize a Rule Preserving Telemedicine Prescribing of Lifesaving Addiction Treatment
Full story -
The ASAM Weekly for September 24th, 2024
Risk of Incident Psychosis and Mania With Prescription AmphetaminesFull story -
Addiction Medicine Experts Convene in DC to Advance Three Meaningful Policies Addressing America’s Addiction and Overdose Crisis
Full story -
The ASAM Weekly for September 17th, 2024
Cannabis Laws and Utilization of Medications for the Treatment of Mental Health DisordersFull story -
The ASAM Weekly for September 10th, 2024
September is National Recovery MonthFull story -
ASAM Joins Letters to CMS on Maternal Health and Custody Exclusion
ASAM signs on to Medicare maternal health and custody exclusion advocacy efforts.Full story -
Fall 2024 Federal Regulatory Update
ASAM's fall 2024 regulatory updateFull story -
ASAM Provides Comments to CMS on Proposed Actions to Improve Access to SUD Treatment
ASAM comments on 2025 proposals from CMS.Full story -
Legal Action Center Highlights Resources on the Residential Recovery for Seniors Act
The Legal Action Center has compiled resources about the Residential Recovery for Seniors Act (RRSA).Full story -
The ASAM Weekly for September 3rd, 2024
Virtual reality-based Mindfulness-Oriented Recovery Enhancement (MORE-VR)Full story -
The ASAM Weekly for August 27th, 2024
The Lancet Psychiatry Commission on Youth Mental HealthFull story -
The ASAM Weekly for August 20th, 2024
Alcohol Consumption Patterns and Mortality Among Older AdultsFull story -
The ASAM Weekly for August 13th, 2024
Physicians not widely adopting evidence-based practices to help reduce addiction morbidity and mortalityFull story -
Guest Editorial: Physicians not widely adopting evidence-based practices to help reduce addiction morbidity and mortality
By now, addiction specialists understand the depth and impact of the drug overdose death crisis in the United States. We’ve read that, “Drug overdoses are one of the leading causes of injury death in adults and have risen over the past several decades… In 2022, 107,941 drug overdose deaths occurred.” Studies published in the past year alone highlight the toll overdose is taking on communities and families, with health disparities and inequities in care often exacerbating negative health outcomes for those most in need.Full story -
ASAM Applauds Bipartisan Legislation to Close the Medicare Coverage Gap for Community-Based Residential Addiction Treatment
Full story -
The ASAM Weekly for August 6th, 2024
Rapid Initiation of Injectable Extended-Release Naltrexone for Opioid Use Disorder: A Time for Paradigm Shift in Treatment ProtocolsFull story -
Guest Editorial: Rapid Initiation of Injectable Extended-Release Naltrexone for Opioid Use Disorder: A Time for Paradigm Shift in Treatment Protocols
The opioid crisis remains a critical public health issue in the United States, contributing to over 80,000 opioid overdose deaths in 2023 alone.Full story -
ASAM and KYSAM Urge KBML to Stop Proposed Treatment Rules, Call for New Workgroup to Form
Full story